Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2003
05/01/2003WO2003035690A2 Hybrid and fusion polypeptide subunits of k+ channels
05/01/2003WO2003035689A1 Process for reducing immunogenic reactions using selective th1 cell binding antibodies
05/01/2003WO2003035688A2 Targeted thrombosis by tissue factor polypeptides
05/01/2003WO2003035687A1 Nogo receptor homologues and their use
05/01/2003WO2003035686A2 Compositions of fsh with high sialylation degree and their use for the preparation of medicaments
05/01/2003WO2003035685A1 Use of a half-transporter protein of the abcg-family for selecting cells and in gene therapy
05/01/2003WO2003035684A1 Ee3-protein family and corresponding dna sequences
05/01/2003WO2003035683A2 Surfactant protein-d and atherosclerosis
05/01/2003WO2003035682A2 Peptides and protins binding to glu-pro motidfs, therapeutical compositions containing them and their applications
05/01/2003WO2003035681A2 Mycobacterial genes down-regulated during latency
05/01/2003WO2003035680A1 Infectious salmon anaemia virus vaccine
05/01/2003WO2003035679A2 Molecules
05/01/2003WO2003035678A2 Sperm factor sequences
05/01/2003WO2003035677A2 Antimicrobial peptides from the venom of the spider cupiennius salei
05/01/2003WO2003035676A1 Groel chimeric protein and vaccine
05/01/2003WO2003035110A1 Treating vascular disease by inhibiting toll-like receptor-4
05/01/2003WO2003035106A1 Methods and compositions for inducing an immune response by co-administering a chemokine with an antigen
05/01/2003WO2003035105A2 A synthetic chimeric fusion protein with immuno-therapeutic uses
05/01/2003WO2003035097A1 A method for identification and development of therapeutic agents
05/01/2003WO2003035096A1 Soluble proteins that inhibit cytokine signal transduction pathways
05/01/2003WO2003035010A2 Thymosin augmentation of genetic immunization
05/01/2003WO2003035006A2 Amyloid ss is a ligand for fpr class receptors
05/01/2003WO2003034990A2 Angiopoietins and methods of use thereof
05/01/2003WO2003034984A2 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003WO2003034981A2 Prevention of recurrent viral disease
05/01/2003WO2003034903A2 Psma antibodies and protein multimers
05/01/2003WO2003034814A1 Regulation of ethylene sensitivity during leaf and flower abscission
05/01/2003WO2003026409A3 Kv1.7 potassium channel disruptions, compositions and methods relating thereto
05/01/2003WO2003012053A8 Identification of receptor and heparin binding sites in fgf4 by structure-based mutagenesis
05/01/2003WO2003008597A3 Regulation of peroxisomal fatty acid transport in plants
05/01/2003WO2003006483A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
05/01/2003WO2003004685A3 Soluble steroidal peptides for nucleic acid delivery
05/01/2003WO2003004680A3 Atherosclerosis susceptibility gene locus 1 (athsq1) and 2 (athsq2)
05/01/2003WO2003002591A3 Tlp antigen extract, its preparation and diagnostic applications thereof
05/01/2003WO2003002152A3 Stabilized formulations of interferons with sulfoalkyl ether cyclodextrins
05/01/2003WO2003000277A3 Antimicrobial peptides
05/01/2003WO2002100340A3 Improved vaccination against anthrax
05/01/2003WO2002100199A3 Modifying nicotine and nitrosamine levels in tobacco
05/01/2003WO2002090553A3 Recombinant fusion proteins and the trimers thereof
05/01/2003WO2002090519A3 Mutant p21?cip1/waf1¿ and cell growth control
05/01/2003WO2002088183A3 G-protein coupled receptor
05/01/2003WO2002083734A3 Modified calcitonin
05/01/2003WO2002083712A3 Transporters and ion channels
05/01/2003WO2002083710A3 Removal of bacterial endotoxin in a protein solution by immobilized metal affinity chromatography
05/01/2003WO2002083183A3 Stimulation of the immune system
05/01/2003WO2002081520A3 Single chain dimeric polypeptides derived from the vegf family
05/01/2003WO2002081513A3 Disease-associated protein
05/01/2003WO2002078630A3 Tub 3'-variant
05/01/2003WO2002077231A3 Nucleic acid-associated proteins
05/01/2003WO2002074806A3 New interferon beta-like molecules
05/01/2003WO2002074799A3 Pepsin-sensitive modified bacillus thuringiensis insecticidal toxin
05/01/2003WO2002072755A3 Polynucleotide encoding a novel human g-protein coupled receptor, hgprbmy27
05/01/2003WO2002070548A3 Modified human granulocyte macrophage colony stimulating factor (gm-csf) with reduced immunogenicity
05/01/2003WO2002068668A3 Compositions and methods for production cell culture
05/01/2003WO2002068471A3 Nucleic acid molecules and polypeptides for a human cation channel polypeptide
05/01/2003WO2002066645A3 Mutant pro-neurotrophin with improved activity
05/01/2003WO2002064783A3 Novel cofactors of the estrogen receptor beta and methods of use
05/01/2003WO2002063007A3 TIMM8b-RELATED PROTEIN
05/01/2003WO2002062378A3 Hyperblebbing bacterial strains and use thereof for production of vaccines
05/01/2003WO2002057456A3 Regulators of fungal gene expression
05/01/2003WO2002055703A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/01/2003WO2002053741A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/01/2003WO2002053586A3 Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them
05/01/2003WO2002044332A3 Prostate polynucleotides and uses
05/01/2003WO2002042460A3 Compositions and methods relating to colon specific genes and proteins
05/01/2003WO2002040544A9 Mutant human factor ix with an increased resistance to inhibition by heparin
05/01/2003WO2002040513A9 Nucleic acid vaccine comprising a fusion protein including an adjuvant sequence from a plant viral coat protein
05/01/2003WO2002038600A3 C. elegans genes involved in viability and/or reproduction and uses thereof
05/01/2003WO2002034910A3 Method for modulating granzyme b uptake and for identifying modulators thereof
05/01/2003WO2002031149A9 Polyvalent cation-sensing receptor proteins in aquatic species
05/01/2003WO2002031148A3 Mammalian wnt polypeptide-5
05/01/2003WO2002005146A3 Method for disigning protein libraries with altered immunogenicity
05/01/2003WO2001098478A3 Clk-2, cex-7 and coq-4 genes, and uses thereof
05/01/2003WO2001098346A3 Methods and compositions for the treatment of peripheral artery disease
05/01/2003WO2001079291A3 Secreted proteins
05/01/2003WO2001066572A3 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof
05/01/2003WO2001024681A3 Alterations in the long qt syndrome genes kvlqt1 and scn5a and methods for detecting same
05/01/2003WO2000071564A3 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
05/01/2003US20030084486 Root-preferred promoters and their use
05/01/2003US20030084483 Methods and means for modification of plant characteristics
05/01/2003US20030084480 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acid levels
05/01/2003US20030084477 Genes enhancing disease resistance in plants
05/01/2003US20030084475 Nucleic acid fragments and proteins affecting storage organelle formation and methods of use
05/01/2003US20030084470 Nucleic acid encoding GAI gene of arabidopsis thaliana
05/01/2003US20030084469 Fish growth hormones
05/01/2003US20030084465 Animal is sensitized to selected antigen by administering antigen or nucleic acid encoding antigen; preferred antigens are anaphylactic antigens; sensitized animal can be used to screen for compounds which may help to cure allergies
05/01/2003US20030084464 Methods of detecting genetic alterations associated with abdominal wall defects; gastroschisis
05/01/2003US20030084463 Method for the production of a protein
05/01/2003US20030083488 DNA encoding orphan SNORF66 receptor
05/01/2003US20030083487 Progestogen receptor polypeptides, transgenic cells in which genes encoding said polypeptides are introduced and method for detecting disruptors for progestogens by using said transgenic cells
05/01/2003US20030083486 Physiologically active protein originating in mammals
05/01/2003US20030083485 Nucleotide sequences coding polypeptide for use the treament of cardiovascular disorders
05/01/2003US20030083482 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation disorders
05/01/2003US20030083481 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of prostate cancer
05/01/2003US20030083479 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030083478 Nucleotide sequences coding polypeptide for use in the treatment of cardiovascular, fertility, contraceptive and urogenital disorders
05/01/2003US20030083474 Streptavidin-binding peptide for use as diagnostic tool in genetic engineering
05/01/2003US20030083472 Cell surface molecule mediating cell adhesion and signal transmission
05/01/2003US20030083471 Method for purification of proteins
05/01/2003US20030083470 Polypeptide for use in controlling gene transcription and treating cancer
1 ... 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 1625 1626 1627 1628 1629 1630 1631 1632 1633 1634 ... 2916